Apotex, the generic drug company that murdered billionaire Barry Sherman built, has recently paid almost $100 million (U.S.) to the U.S. government and the state of Texas over allegations it conspired with competitors to hike prices of popular drugs. And the other 49 states are in court alleging Apotex and other firms have engaged in a widespread pattern of price fixing.
In the U.S. government case, Apotex admitted to a conspiracy to “suppress and eliminate competition,” escaping a criminal conviction that would likely have barred it from the lucrative American market, according to the U.S. Justice Department. As its part of the deal, Apotex must co-operate with investigations of rivals, including recording telephone conversations, introducing law enforcement to sources, or testifying before a grand jury, documents filed in court say.
